Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways

被引:104
|
作者
Larauche, Muriel [1 ,2 ]
Gourcerol, Guillaume [1 ,2 ]
Wang, Lixin [1 ,2 ]
Pambukchian, Karina [1 ,2 ]
Brunnhuber, Stefan [1 ,2 ]
Adelson, David W. [1 ,2 ]
Rivier, Jean [4 ]
Million, Mulugeta [1 ,2 ]
Tache, Yvette [1 ,2 ,3 ]
机构
[1] Univ Calif Los Angeles, CURE Digest Dis Res Ctr, Los Angeles, CA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Ctr Neurobiol Stress,Dept Med, Los Angeles, CA 90095 USA
[3] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA
[4] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA USA
关键词
CRF1; agonist; colonic motility; visceral pain; rat; mice; colonic permeability; astressin; CP-154,526; CORTICOTROPIN-RELEASING-FACTOR; IRRITABLE-BOWEL-SYNDROME; COLORECTAL DISTENSION; RECEPTOR ANTAGONIST; DIARRHEA-PREDOMINANT; RECTAL DISTENSION; MOTOR FUNCTION; UROCORTIN-II; HORMONE; RESPONSES;
D O I
10.1152/ajpgi.00072.2009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Larauche M, Gourcerol G, Wang L, Pambukchian K, Brunnhuber S, Adelson DW, Rivier J, Million M, Tache Y. Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways. Am J Physiol Gastrointest Liver Physiol 297: G215-G227, 2009. First published April 30, 2009; doi:10.1152/ajpgi.00072.2009.-Corticotropin-releasing factor (CRF) 1 receptor (CRF1) activation in the brain is a core pathway orchestrating the stress response. Anatomical data also support the existence of CRF signaling components within the colon. We investigated the colonic response to intraperitoneal (ip) injection of cortagine, a newly developed selective CRF1 peptide agonist. Colonic motor function and visceral motor response (VMR) were monitored by using a modified miniaturized pressure transducer catheter in adult conscious male Sprague-Dawley rats and C57Bl/6 mice. Colonic permeability was monitored by the Evans blue method and myenteric neurons activation by Fos immunohistochemistry. Compared with vehicle, cortagine (10 mu g/kg ip) significantly decreased the distal colonic transit time by 45% without affecting gastric transit, increased distal and transverse colonic contractility by 35.6 and 66.2%, respectively, and induced a 7.1-fold increase in defecation and watery diarrhea in 50% of rats during the first hour postinjection whereas intracerebroventricular (icv) cortagine (3 mu g/rat) had lesser effects. Intraperitoneal (ip) cortagine also increased colonic permeability, activated proximal and distal colonic myenteric neurons, and induced visceral hypersensitivity to a second set of phasic colorectal distention (CRD). The CRF antagonist astressin (10 mu g/kg ip) abolished ip cortagine-induced hyperalgesia whereas injected icv it had no effect. In mice, cortagine (30 mu g/kg ip) stimulated defecation by 7.8-fold, induced 60% incidence of diarrhea, and increased VMR to CRD. Stresslike colonic alterations induced by ip cortagine in rats and mice through restricted activation of peripheral CRF1 receptors support a role for peripheral CRF1 signaling as the local arm of the colonic response to stress.
引用
收藏
页码:G215 / G227
页数:13
相关论文
共 11 条
  • [1] Stimulation of the amygdala induces colonic hypersensitivity through a CRF1 receptor-mediated mechanism in rats.
    Greenwood-Van Meerveld, B
    Maline, MG
    Gibson, M
    Cochrane, S
    Myers, DA
    GASTROENTEROLOGY, 2002, 122 (04) : A382 - A383
  • [2] Selective agonists of somatostatin receptor subtype 1 or 2 prevent visceral hyperalgesia induced by activation of peripheral CRF1 receptors with cortagine in mice
    Larauche, M.
    Mulak, A.
    Million, M.
    Rivier, J.
    Tache, Y.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 : 139 - 139
  • [3] Selective peripheral activation of corticotropin-releasing factor (CRF) receptor type 1 (CRF1) by cortagine:: A new model of IBS-D-like symptoms in rodents
    Larauche, Muriel H.
    Yuan, Pu-Qing
    Gourcerol, Guillaume
    Wang, Lixin
    Pambukchian, Karina
    Brunnhuber, Stefan
    Adelson, David W.
    Million, Mulugeta
    Rivier, Jean E.
    Tache, Yvette
    GASTROENTEROLOGY, 2008, 134 (04) : A277 - A277
  • [4] Distinct role of CRF 1/2 pathways in distal colonic motility activation in conscious rats:: evidence For a peripheral CRF1 pathway
    Gourcerol, G.
    Larauche, M.
    Million, M.
    Adelson, D.
    Tache, Y.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 39 - 39
  • [5] CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity:: implications for irritable bowel syndrome
    Taché, Y
    Martinez, V
    Wang, L
    Million, M
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (08) : 1321 - 1330
  • [6] Role of corticotropin-releasing factor-1 (CRF1)-receptor mediated mechanisms in neural pathways modulating colonic hypersensitivity
    Cochrane, SW
    Gibson, MS
    Myers, DA
    Schulkin, J
    Rice, KC
    Gold, PW
    Greenwood-Van Meerveld, B
    GASTROENTEROLOGY, 2001, 120 (05) : A7 - A7
  • [7] The new CRF, selective agonist cortagine injected peripherally and centrally stimulates colonic motor function and induces diarrhea in rats: A relevant tool for stress-related gastrointestinal disease studies
    Larauche, Muriel H.
    Pambukchian, Karina
    Karapetyan, Armen
    Million, Mulugeta
    Rivier, Jean
    Tache, Yvette
    GASTROENTEROLOGY, 2006, 130 (04) : A5 - A5
  • [8] Intracerebroventricular Corticotropin-Releasing Factor (CRF) at Low Doses Induces a CRF1 Receptor-Mediated Visceral Analgesia in Male Rats Through Recruitment of Brain Oxytocin
    Larauche, Muriel H.
    Biraud, Mandy
    Moussaoui, Nabila
    Bae, Won Ki
    Duboc, Henri
    Million, Mulugeta
    Liang, Honghui
    Tache, Yvette
    GASTROENTEROLOGY, 2016, 150 (04) : S16 - S16
  • [9] A novel water-soluble selective CRF1 receptor antagonist, NBI 35965, blunts stress-induced visceral hyperalgesia and colonic motor function in rats
    Million, M
    Grigoriadis, DE
    Sullivan, S
    Crowe, PD
    McRoberts, JA
    Zhou, HP
    Saunders, PR
    Maillot, C
    Mayer, EA
    Taché, Y
    BRAIN RESEARCH, 2003, 985 (01) : 32 - 42
  • [10] FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF1 agonist mediated visceral hypersensitivity in male rats
    Larauche, Muriel
    Mulak, Agata
    Ha, Chrysanthy
    Million, Mulugeta
    Arnett, Stacy
    Germano, Peter
    Pearson, James P.
    Currie, Mark G.
    Tache, Yvette
    NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 36 (12):